Oct 2026· International Journal of Cardiology· pp.
135023
· 0 citations· 41 references
Medicine
TL;DR
Carotid and femoral PB by 3DVUS identifies distinct pathophysiological phenotypes in eCAD, underscoring the value of atherosclerosis assessment for individualized management and prevention.
Abstract
Background
Early coronary artery disease events (eCAD) are increasing, occasionally occurring in individuals with minimal atherosclerosis, suggesting heterogeneous underlying mechanisms. We report, for the first time, carotid and femoral plaque burden in eCAD patients, relate it to underlying phenotypes, and compare it with the PESA reference cohort to explore preventive implications.
Methods
eCAD patients (<60 years) were consecutively and prospectively enrolled at a tertiary hospital. Conventional and non-conventional cardiovascular risk factors (CVRF) and blood biomarkers were assessed, and global atherosclerosis plaque burden (GPB) was quantified as total carotid and femoral plaque volume by 3-dimensional vascular ultrasound (3DVUS).
Results
Among 231 eCAD patients (53 ± 5 years old; 14% women; 23% with a prior event; 52% presented with STEMI) conventional CVRF were frequent but prevalence of non-conventional CVRF was high (28% elevated lipoprotein a, 25% family history of eCAD, 25% hyperuricemia, and 14% hyperhomocysteinemia). Underlying GPB was high (268.7 mm3 [IQR75.2-509.9]), being higher in the femoral than the carotid territory (200.6 mm3 [IQR51.7-420.7] vs 35.2 mm3 [IQR7.9-96.2], p < 0.001), and increased with age. Compared with age-matched asymptomatic individuals (PESA study), eCAD patients had markedly higher GPB (284.1 mm3 [IQR110-546.8] vs 50.8 mm3 [18.7-121.5]). However, GPB in eCAD patients varied widely. Severe GBP (percentile≥75th) identified a subgroup with predominantly conventional CVRF and prior CAD, with marginal presence of non-conventional factors, compared with those with no-or-mild GPB (percentile≤25th).
Conclusion
Carotid and femoral PB by 3DVUS identifies distinct pathophysiological phenotypes in eCAD, underscoring the value of atherosclerosis assessment for individualized management and prevention.
Coronary artery disease (CAD) is still the major cause of cardiovascular mortality and morbidity. Despite progresses in treatment a substantial residual risk (RR) of CAD and associated events persists. The role of cardiometabolic determinants of RR is emerging but the relationship with CAD risk phenotypes in pati...
D. Neglia, M. Occhipinti, K. Pane et al.· European Heart Journal· 0 citations
The rising incidence of early coronary artery disease (eCAD) events, and their recurrence despite medical management, represents a major public health concern, driven by heterogeneous and poorly understood mechanisms. Genetic burden, particularly polygenic risk, is becoming a key determinant of eCAD beyond cardio...
B. S. Martin, I. Kirrout, N. Montes et al.· European Heart Journal· 0 citations
Background This study provides an overview of the results of carotid screening for the prevention of cardiovascular disease. Methods Between 2009 and 2026, 11,540 individuals, 45% of whom were women, aged 20–65 years without clinical signs of cardiovascular disease, underwent carotid ultrasound examinations. Over 8,800...
Ansgar Adams, Michel J. Romanens· Cardiology Research· 0 citations
INTRODUCTION
Carotid plaques (CP) reflect systemic atherosclerotic burden and may predict cardiovascular (CV) events.
OBJECTIVES
The aim of the study was to assess CP burden in a general adult urban population and its associations with fat distribution with adjustment for known CV risk factors.
PATIENTS AND METHODS...
Wojciech Łaguna, M. Chlabicz, M. Dubatówka et al.· Polish Archives of Internal...· 0 citations
The findings support AIP as a practical tool not only for early risk stratification but also for guiding intensive lipid-lowering therapy in this distinct population of young CAD patients.
Jia-Yin Sun, Jia-Yi Liu, Yu-Ning Wang et al.· Journal of Clinical Medicine· 0 citations
Coronary artery disease (CAD) is highly heritable and clinical risk scores may insufficiently capture the full spectrum of individual risk. We investigated whether integrated polygenic risk score (iPRS) derived from a combination of genetic and clinical risk factors is associated with coronary plaque phenotypes a...
B. Weijs, N. Nurmohamed, D. Ratman et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.